Cargando…

Multiparametric MRI in the PSA Screening Era

Prostate cancer remains significant public health concern amid growing controversies regarding prostate specific antigen (PSA) based screening. The utility of PSA has been brought into question, and alternative measures are investigated to remedy the overdetection of indolent disease and safeguard p...

Descripción completa

Detalles Bibliográficos
Autores principales:	George, Arvin K., Pinto, Peter A., Rais-Bahrami, Soroush
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163437/ https://www.ncbi.nlm.nih.gov/pubmed/25250323 http://dx.doi.org/10.1155/2014/465816

Ejemplares similares

Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided
por: Rothwax, Jason T., et al.
Publicado: (2014)

Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
por: Venkatesan, Aradhana M., et al.
Publicado: (2021)

Metastatic prostate cancer in the modern era of PSA screening
por: Fontenot, Philip A., et al.
Publicado: (2017)

Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies
por: Akin, Oguz, et al.
Publicado: (2023)

Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
por: Dulaney, Caleb R., et al.
Publicado: (2016)

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
por: Wallström, Jonas, et al.
Publicado: (2021)

Incidental Bladder Cancer Detected on Multiparametric Magnetic Resonance Imaging of the Prostate Gland
por: Sardari, Al, et al.
Publicado: (2015)

Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

Metastatic prostate cancer to an ischiorectal fossa lymph node identified on multiparametric magnetic resonance imaging
por: Fang, Andrew M., et al.
Publicado: (2020)

A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators
por: Patel, Hiten D., et al.
Publicado: (2022)

Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlation
por: Lai, Win Shun, et al.
Publicado: (2017)

A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score
por: Chen, Zongxin, et al.
Publicado: (2023)

MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
por: Glaser, Zachary A., et al.
Publicado: (2018)

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
por: Pye, Hayley, et al.
Publicado: (2021)

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?
por: Abd-Alazeez, Mohamed, et al.
Publicado: (2014)

Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era
por: Wei, Melissa Y., et al.
Publicado: (2012)

Multiparametric-MRI in diagnosis of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2015)

Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer
por: Glaser, Zachary A., et al.
Publicado: (2018)

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA
por: Müller, Stig, et al.
Publicado: (2018)

PSA mass screening: is there enough evidence?
por: Rocco, Bernardo, et al.
Publicado: (2012)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Comparison of Multiparametric and Biparametric MRI in First Round Cognitive Targeted Prostate Biopsy in Patients with PSA Levels under 10 ng/mL
por: Lee, Dong Hoon, et al.
Publicado: (2017)

An Overview of the Role of Multiparametric MRI in the Investigation of Testicular Tumors
por: Tsili, Athina C., et al.
Publicado: (2022)

Upgrading prostate cancer following proton beam therapy
por: Logan, Jennifer K., et al.
Publicado: (2015)

Could Biparametric MRI Replace Multiparametric MRI in the Management of Prostate Cancer?
por: Iacob, Roxana, et al.
Publicado: (2023)

Multiparametric MRI evaluation of bone sarcomas in children
por: Inarejos Clemente, Emilio J., et al.
Publicado: (2022)

Multiparametric MRI - Local Staging of Prostate Cancer and Beyond
por: Caglic, Iztok, et al.
Publicado: (2019)

Multiparametric MRI in Prostate Cancer
por: Esen, Tarık, et al.
Publicado: (2014)

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends
por: Bardis, Michelle D., et al.
Publicado: (2020)

Four‐year outcomes from a multiparametric magnetic resonance imaging (MRI)‐based active surveillance programme: PSA dynamics and serial MRI scans allow omission of protocol biopsies
por: Gallagher, Kevin Michael, et al.
Publicado: (2018)

Multiparametric MRI for Localized Prostate Cancer: Lesion Detection and Staging
por: Margolis, Daniel J. A.
Publicado: (2014)

The Role of Imaging in Bladder Cancer Diagnosis and Staging
por: Galgano, Samuel J., et al.
Publicado: (2020)

An evaluation of social media utilization by general surgery programs in the COVID-19 era
por: Fang, Hua A., et al.
Publicado: (2021)

DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy
por: Dulaney, Caleb R., et al.
Publicado: (2017)

CLIPPERS: Multiparametric and quantitative MRI features
por: Korostyshevskaya, Alexandra M., et al.
Publicado: (2022)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
por: Wever, E M, et al.
Publicado: (2012)

Evaluation of PCA3 and multiparametric MRI’s: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL
por: Okcelik, Sezgin, et al.
Publicado: (2016)

Clinical significance of multiparametric MRI and PSA density as predictors of residual tumor (pT0) following radical prostatectomy for T1a-T1b (incidental) prostate cancer
por: Chung, Doo Yong, et al.
Publicado: (2018)

Multiparametric Quantitative MRI in Neurological Diseases
por: Seiler, Alexander, et al.
Publicado: (2021)

Personalized prostate cancer care
por: Rais-Bahrami, Soroush, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_neoq7ej6kkarlth37lctt8sopi